Company Search:
Advanced Search
Sponsored Links
TG Therapeutics Inc Company Snapshot
TG Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares TG Therapeutics Inc with three other companies in this sector in the United States: Karyopharm Therapeutics Inc (2016 sales of $154,000.00 ), Mabvax Therapeutics Holdings Inc ($148,054.00 ), and Anthera Pharmaceuticals, Incorporation ($145,000.00 of which 100% was Biopharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
TG Therapeutics Inc
  Stock Performance Chart for TG Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 9.35
(Figures in U.S. Dollars)
1 Week -5.3%   13 Weeks 10.0%  
4 Weeks 8.7%   52 Weeks 122.6%  
TG Therapeutics Inc Key Data:
  Ticker: TGTX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 152,381
(Year Ending Jan 2017).
Employees: 6
  Currency: U.S. Dollars Market Cap: 660,598,696
  Fiscal Yr Ends: December Shares Outstanding: 70,652,267
  Share Type: Common Closely Held Shares: 14,074,687
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.